LCTX
AMEX · Biotechnology
Lineage Cell Therapeutics In
$1.03
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,824.3% upside
Low Target
$29.91
Average Target
$40.42
High Target
$53.83
Current Price
$1.03
Current
$1.03
$1.03
Target
$40.42
$40.42
$29.91
$40.42 avg
$53.83
Scenario Analysis
Bear Case
$29.91
2,803.9%
Low target
Base Case
$40.42
+3,824.3%
Avg target
Bull Case
$53.83
+5,126.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.09
-50.7% from high
52-Week Low
$1.00
+3.0% from low
Target vs 52W High
$40.42
+1,834.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |